UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers: an emerging paradigm

Nature reviews. Clinical oncology, 2021-08, Vol.18 (8), p.473-487

2021

Volltextzugriff (PDF)

Targeting the HGF/MET pathway in gastric cancer

The lancet oncology, 2014-08, Vol.15 (9), p.914-916

Lordick, Florian

2014

Volltextzugriff (PDF)

Depression and anxiety in long-term survivors 5 and 10 years after cancer diagnosis

Supportive care in cancer, 2020-01, Vol.28 (1), p.211-220

2020

Volltextzugriff (PDF)

National guidelines for gastric cancer: redundant or needed?

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2024-01, Vol.27 (1), p.3-5

2024

Volltextzugriff (PDF)

Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer

Journal of clinical oncology, 2020-12, Vol.38 (35), p.4138-4148

2020

Volltextzugriff (PDF)

Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study

Journal of clinical oncology, 2022-09, Vol.40 (26), p.3065-3076

2022

Volltextzugriff (PDF)

Optimal chemotherapy for advanced gastric cancer: is there a global consensus?

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2014-04, Vol.17 (2), p.213-225

2014

Volltextzugriff (PDF)

Wirksamere Therapien bei Magenkrebs erreichen die Praxis

Im Fokus Onkologie, 2024-02, Vol.27 (1), p.3-3

Lordick, Florian

2024

Volltextzugriff (PDF)

Patient-reported outcomes from the phase II FAST trial of zolbetuximab plus EOX compared to EOX alone as first-line treatment of patients with metastatic CLDN18.2+ gastroesophageal adenocarcinoma

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2021-05, Vol.24 (3), p.721-730

2021

Volltextzugriff (PDF)

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

The Lancet (British edition), 2010-08, Vol.376 (9742), p.687-697

2010

Volltextzugriff (PDF)

Covid-19 in outpatients-Is fever a useful indicator for SARS-CoV-2 infection?

PloS one, 2021-02, Vol.16 (2), p.e0246312-e0246312

2021

Volltextzugriff (PDF)

Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial

The lancet oncology, 2013-05, Vol.14 (6), p.490-499

2013

Volltextzugriff (PDF)

Primary and metastatic peritoneal surface malignancies

Nature reviews. Disease primers, 2021-12, Vol.7 (1), p.91-91, Article 91

2021

Volltextzugriff (PDF)

EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group

BMC cancer, 2019-05, Vol.19 (1), p.494-494, Article 494

2019

Volltextzugriff (PDF)

Correction: Covid-19 in outpatients-Is fever a useful indicator for SARS-CoV-2 infection?

PloS one, 2021-05, Vol.16 (5), p.e0251623-e0251623

2021

Volltextzugriff (PDF)

PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial

The lancet oncology, 2007-09, Vol.8 (9), p.797-805

2007

Volltextzugriff (PDF)

Physical and psychosocial factors associated with sexual satisfaction in long-term cancer survivors 5 and 10 years after diagnosis

Scientific reports, 2023-02, Vol.13 (1), p.2011-2011, Article 2011

2023

Volltextzugriff (PDF)

Vitamin D und Omega-3-Fettsäuren senken das Risiko für Krebs und kardiovaskuläre Ereignisse nicht

Strahlentherapie und Onkologie, 2019-07, Vol.195 (7), p.693-694

Lordick, Florian

2019

Volltextzugriff (PDF)

Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954

Journal of clinical oncology, 2010-12, Vol.28 (35), p.5210-5218

2010

Volltextzugriff (PDF)

ESMO management and treatment adapted recommendations in the COVID-19 era: colorectal cancer

ESMO open, 2020-05, Vol.5 (Suppl 3), p.e000826-e000826, Article e000826

2020

Volltextzugriff (PDF)

Molecular Targets for Gastric Cancer Treatment and Future Perspectives from a Clinical and Translational Point of View

Cancers, 2021-10, Vol.13 (20), p.5216

2021

Volltextzugriff (PDF)

VESTIGE: Adjuvant Immunotherapy in Patients With Resected Esophageal, Gastroesophageal Junction and Gastric Cancer Following Preoperative Chemotherapy With High Risk for Recurrence (N+ and/or R1): An Open Label Randomized Controlled Phase-2-Study

Frontiers in oncology, 2020-01, Vol.9, p.1320-1320

2020

Volltextzugriff (PDF)

Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer

Journal of clinical oncology, 2010-11, Vol.28 (31), p.4706-4713

2010

Volltextzugriff (PDF)

To resect or not resect in metastatic gastric cancer: that is the question

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2012-07, Vol.15 (3), p.229-231

Lordick, Florian

2012

Volltextzugriff (PDF)

1 – 25 von 596

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(474)
Mit Volltextzugriff
(497)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(464)
Deutsch
(134)
Japanisch
(37)
Koreanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(285)
Life Sciences & Biomedicine
(281)
Oncology
(271)
Humans
(234)
Female
(120)
Male
(120)
Middle Aged
(106)
Aged
(94)
Chemotherapy
(92)
Gastric Cancer
(91)
Medicine
(82)
Medicine & Public Health
(82)
Adult
(72)
Cancer
(72)
Treatment Outcome
(66)
Tumors
(61)
Surgery
(59)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(58)
Patients
(57)
Prognosis
(55)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers: an emerging paradigm

Targeting the HGF/MET pathway in gastric cancer

Depression and anxiety in long-term survivors 5 and 10 years after cancer diagnosis

National guidelines for gastric cancer: redundant or needed?

Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer

Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial

Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study

Optimal chemotherapy for advanced gastric cancer: is there a global consensus?

Wirksamere Therapien bei Magenkrebs erreichen die Praxis

Patient-reported outcomes from the phase II FAST trial of zolbetuximab plus EOX compared to EOX alone as first-line treatment of patients with metastatic CLDN18.2+ gastroesophageal adenocarcinoma

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

Covid-19 in outpatients-Is fever a useful indicator for SARS-CoV-2 infection?

Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial

Primary and metastatic peritoneal surface malignancies

Correction: Covid-19 in outpatients-Is fever a useful indicator for SARS-CoV-2 infection?

PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial

Physical and psychosocial factors associated with sexual satisfaction in long-term cancer survivors 5 and 10 years after diagnosis

Vitamin D und Omega-3-Fettsäuren senken das Risiko für Krebs und kardiovaskuläre Ereignisse nicht

Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954

ESMO management and treatment adapted recommendations in the COVID-19 era: colorectal cancer

Molecular Targets for Gastric Cancer Treatment and Future Perspectives from a Clinical and Translational Point of View

VESTIGE: Adjuvant Immunotherapy in Patients With Resected Esophageal, Gastroesophageal Junction and Gastric Cancer Following Preoperative Chemotherapy With High Risk for Recurrence (N+ and/or R1): An Open Label Randomized Controlled Phase-2-Study

Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer

To resect or not resect in metastatic gastric cancer: that is the question

Suchergebnisse filtern